Population pharmacokinetic modelling of imatinib in healthy subjects receiving a single dose of 400 mg.
Purpose: Imatinib is indicated for treatment of CML, GIST, etc. The population pharmacokinetics (popPK) of imatinib in patients under long-term treatment are reported in literature. Data obtained from bioequivalence trials for healthy subjects were used to evaluate the influence of demographic and p...
| Publicado en: | Cancer Chemotherapy & Pharmacology Vol. 90; no. 2; pp. 125 - 137 |
|---|---|
| Autores principales: | , , , , , , , , |
| Formato: | equations & formulas research tables/charts Journal Article |
| Publicado: |
Springer Nature
Aug2022
|
| Acceso en línea: | Ver este registro en EBSCOhost |